Your browser doesn't support javascript.
loading
[Research and application of the SARS-CoV-2 vaccine based on adenovirus vector technology platform].
Zhang, Y; Yu, W Z; Yin, Z D; Wang, T Z; Sun, X D; Xu, A Q.
Affiliation
  • Zhang Y; Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
  • Yu WZ; National Immunization Programme, China Center for Disease Control and Prevention, Beijing 100050, China.
  • Yin ZD; National Immunization Programme, China Center for Disease Control and Prevention, Beijing 100050, China.
  • Wang TZ; Shandong Center for Disease Control and Prevention/Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Jinan 250014, China.
  • Sun XD; Shanghai Center for Disease Control and Prevention, Shanghai 201204, China.
  • Xu AQ; Shandong Center for Disease Control and Prevention/Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Jinan 250014, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 57(7): 1082-1095, 2023 Jul 06.
Article in Zh | MEDLINE | ID: mdl-37198717
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Limits: Humans Language: Zh Journal: Zhonghua Yu Fang Yi Xue Za Zhi Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Limits: Humans Language: Zh Journal: Zhonghua Yu Fang Yi Xue Za Zhi Year: 2023 Type: Article Affiliation country: China